Lindgren Theres, Stigbrand Torgny, Råberg Aino, Riklund Katrine, Johansson Lennart, Eriksson David
Department of Clinical Microbiology, Immunology, Umeå University , Umeå , Sweden.
Int J Radiat Biol. 2015 Jan;91(1):99-111. doi: 10.3109/09553002.2015.959668.
To study the kinetics of gene expression alterations following radiation exposure of isogenic HCT116 p53 +/+ and HCT116 p53-/- cell lines.
Cells were exposed to 5 Gy of irradiation (Cs-137) and genome-wide temporal expression analysis using Illumina bead chip arrays was performed. Signalling pathways were explored using Metacore (Genego). Biological responses including cell cycle checkpoint activation, centrosome amplification and senescence induction were analyzed.
Significant differences in the radiation response were observed between the p53+/+ and the p53-/- cell lines. In p53+/+ cells concurrent G1- and G2-arrests were activated followed by senescence induction. Increased expression of genes associated with senescence, senescence associated secretory phenotype (SASP) and repression of genes essential for G2-M transition were detected. P53-/- cells arrested mainly in G2 followed by centrosome amplification, mitotic slippage and a subsequent increase of polyploid cells. Furthermore, changes in expression correlated well with these signs of mitotic catastrophe.
The presence or absence of p53 triggers different signalling cascades with different endpoints. Elucidating these differences is important as it enables improvement of radiation treatment and could be used to develop new combination treatments with specific inhibitors of key regulators of these cell death modalities.
研究同基因HCT116 p53 +/+ 和HCT116 p53 -/- 细胞系受辐射后基因表达改变的动力学。
细胞接受5 Gy的辐射(铯 - 137),并使用Illumina珠芯片阵列进行全基因组时间表达分析。使用Metacore(Genego)探索信号通路。分析包括细胞周期检查点激活、中心体扩增和衰老诱导在内的生物学反应。
在p53 +/+ 和p53 -/- 细胞系之间观察到辐射反应的显著差异。在p53 +/+ 细胞中,同时激活G1期和G2期阻滞,随后诱导衰老。检测到与衰老、衰老相关分泌表型(SASP)相关的基因表达增加以及对G2 - M转换所必需基因的抑制。p53 -/- 细胞主要阻滞在G2期,随后发生中心体扩增、有丝分裂滑移以及多倍体细胞随后增加。此外,表达变化与这些有丝分裂灾难的迹象密切相关。
p53的存在与否触发具有不同终点的不同信号级联反应。阐明这些差异很重要,因为这能够改进放射治疗,并可用于开发与这些细胞死亡方式关键调节因子的特异性抑制剂的新联合治疗方法。